A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal cancer. Patients in a UK-led trial who received just nine weeks of pembrolizumab prior to surgery have remained cancer-free nearly thre…
A new clinical trial suggests that giving immunotherapy before surgery may dramatically improve outcomes for certain colorectal cancer patients. In the NEOPRISM-CRC study, patients treated with a sho… [+5983 chars]